文献速递帕金森病与运动障碍

苍白球神经刺激与X连锁肌张力障碍帕金森综合征的疗效预测因素

Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism.
PubMed 文献 · JAMA Neurol · 2019-01-01

这项前瞻性观察性队列研究纳入16名菲律宾男性XDP患者,在德国吕贝克接受双侧GPi-DBS,随访至46个月。术后1周和6个月肌张力障碍严重程度分别改善55%和59%,UPDRS-III亦改善;尾状核萎缩预测疗效较差。

要点

  • GPi-DBS对以肌张力障碍为主的XDP患者有积极关联,术后1周内即出现反应。
  • 尾状核萎缩与术后获益呈负相关(r=0.817,P=.004),提示应早期考虑手术。
  • 长期随访至46个月证实疗效持续,日常生活能力、疼痛、体重和生活质量等次要终点改善。

核心结论

  • GPi-DBS对以肌张力障碍为主的XDP患者的主要终点有积极关联,并改善生活质量。

研究设计与样本

  • 前瞻性观察性队列研究,2013年2月至2014年12月纳入16名菲律宾男性XDP患者,平均年龄40.9岁,病程1-6年。
  • 所有患者在德国吕贝克单中心接受双侧GPi-DBS,随访至46个月。

主要发现

  • 掩蔽视频评分显示术后1周肌张力障碍严重程度改善55%(范围-94%至59%,P<.01),6个月改善59%(范围-100%至22%,P<.001)。
  • UPDRS-III评分术后1周改善19%(范围-54%至95%),6个月改善27%(范围-70%至124%)。
  • 非掩蔽长期随访证实GPi-DBS疗效持续至术后46个月。
  • 次要终点包括日常生活活动、疼痛严重程度、体重和生活质量均有改善。
  • 尾状核萎缩是疗效较差的预测因素(r=0.817,P=.004)。

临床怎么用

  • 对于以肌张力障碍为主的XDP患者,可考虑GPi-DBS,且鉴于尾状核萎缩与疗效负相关,宜在病程早期评估手术。

局限性

  • 样本量小(16例),为观察性研究,无对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Anecdotal evidence suggests that deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in ameliorating dystonia in X-linked dystonia parkinsonism (XDP), a disease that is usually refractive to medical therapy. OBJECTIVE: To determine the efficacy of GPi-DBS in a cohort of patients with XDP in a prospective study and identify predictors of postoperative outcomes. DESIGN, SETTING, AND PARTICIPANTS: This observational prospective cohort study enrolled patients in February 2013 and was completed in December 2014. The patients were followed up for up to 46 months. Patients from the Philippines were treated in a single center in Lübeck, Germany and followed up in the Philippines. Sixteen men with XDP (mean [SD] age, 40.9 [7.3] years; disease duration, 1-6 years) from the Philippines with predominant dystonia were selected. EXPOSURES: All patients underwent bilateral GPi-DBS in Lübeck, Germany. MAIN OUTCOMES AND MEASURES: Clinical assessment included the motor parts of the Burke-Fahn-Marsden scale (BFMDRS-M) and the Unified Parkinson's Disease Rating Scale (UPDRS-III). T1-based basal ganglia volumetry was performed and correlated with postoperative outcomes. RESULTS: The study participants included 16 Filipino men (mean age, 40.9 years). Masked video ratings revealed significant improvements of dystonia severity 1 week (-55%; range, -94% to 59%; P < .01) and 6 months (-59%; range, -100% to 22%; P < .001) after surgery. The UDPRS-III score also improved, albeit to a lesser extent (-19%; range, -54% to 95%; and -27%; range, -70% to 124%; respectively). Unmasked long-term follow-up confirmed the continued efficacy of GPi-DBS up to 46 months after surgery. Important secondary end points improved, including activities of daily living, pain severity, weight, and quality of life. Caudate atrophy was a predictor of a less beneficial outcome (r = 0.817, P = .004). CONCLUSIONS AND RELEVANCE: Internal globus pallidus DBS had a positive association in XDP with predominant dystonia (the primary end point) and contributed to an improved quality of life (the secondary end point). The response to DBS occurred within 1 week. Given the inverse correlation of postoperative benefit and caudate atrophy, GPi-DBS should be considered early during the disease course. Close international collaboration, training, and funding from multiple sources enabled the sustainable follow-up of patients with XDP in the Philippines.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Brüggemann N, Domingo A, Rasche D, et al. Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism. JAMA Neurol. 2019. PMID: 30508028. doi:10.1001/jamaneurol.2018.3777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。